Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (9): 956-959.doi: 10.3736/jcim20080916

• Original Experimental Research • Previous Articles     Next Articles

Effects of tetrandrine on nuclear factor-kappaB expression in leukemia multidrug-resistant cell line K562/A02

Bao-an Chen1(), Ai-ling Su1, Jian Cheng1, Hui-hui Zhao1, Guo-hong Li1, Xue-mei Wang2   

  1. 1. Department of Hematology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu Province 210009, China
    2. State Key Laboratory of Bioelectronics,School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu Province 210096, China
  • Received:2008-01-24 Online:2008-09-20 Published:2008-09-15

Objective: To investigate the effects of tetrandrine (Tet) on nuclear factor kappaB (NF-κB) expression in leukemia cell line K562 and multidrug-resistant K562/A02 cell line.
Methods: The activations of NF-κB in K562 and K562/A02 cells and the effects of 1 μmol/L Tet on NF-κB expression were determined by immunocytochemistry and Western blot assay.
Results: Tet had no effect on NF-κB expression in K562 cells after 6- and 12-hour treatment (P>0.05), and K562/A02 cells displayed higher level of NF-κB protein expression than their parental K562 cells (P<0.01). Tet could significantly down-regulate NF-κB protein expression and nuclear translocation in K562/A02 cells shown by immunocytochemistry and Western blot, and this decrease became more significant after 12-hour treatment than after at 6-hour treatment (P<0.05).
Conclusion: Activation of NF-κB may have relaton to multidrug resistance of K562/A02 cell line. And the inhibition of NF-κB activation by Tet leads to multidrug resistance reversal in K562/A02 cell line.

Key words: leukemia, multidrug resistance, tetrandrine, nuclear factor kappaB

CLC Number: 

  • R966

Figure 1

Expressions of NF-κB protein of K562/A02 cells cultured in medium containing Tet for 6 hours and 12 hours 1: K562/A02 cell group; 2: K562 cell group; 3: K562/A02 plus 6-hour Tet group; 4: K562/A02 cell group; 5: K562 group; 6: K562/A02 plus 12-hour Tet group."

[1] Nørgaard Hokland P . Biology of multiple drug resistance in acute leukemia[J]. Int J Hematol, 2000,72(3):290-297
doi: 10.1016/S0889-8588(05)70178-7 pmid: 11185984
[2] Jiangsu New Medical College. Dictionary of Chinese Traditional Drugs(Part one)[M]. Shanghai: Shanghai Scientific and Technical Publishers,1975: 791-795
江苏新医学院. 中药大词典(上册)[M]. 上海: 上海科学技术出版社,1975: 791-795
[3] Xia W, Ao ZF, Zhu GR . An effective reversal agent of drug resistance in tumor cells--study on reversal of drug resistance by tetrandrine in leukemic cells[J]. Nanjing Yi Ke Da Xue Xue Bao, 1995,15(3):543-546
夏薇, 敖忠芳, 朱广荣 . 一种有效的肿瘤耐药逆转剂——汉防己甲素逆转白血病耐药的实验研究[J]. 南京医科大学学报, 1995,15(3):543-546
[4] Ao ZF, Xia W . Reversal of daunorubicin resistance by tetrandrine in leukemic cells[J]. Zhonghua Xue Ye Xue Za Zhi, 1995,16(5):235-237, 278
doi: 10.1007/BF02007173
敖忠芳, 夏薇 . 汉防己甲素逆转白血病细胞耐药的研究[J]. 中华血液学杂志, 1995,16(5):235-237, 278
doi: 10.1007/BF02007173
[5] Xu JY, Zhou Q, Shen P , et al. Reversal effect of TTD on human multidrug resistant KBV200 cell line[J]. J Exp Clin Cancer Res, 1999,18(4):549-552
pmid: 10746983
[6] Yang JY, Zeng XY, Ma BR . Effect of NF-κB pathway on apoptosis of hepatic carcinoma cell line-7721 induced by TNF-α[J]. Ai Zheng, 2002,21(9):974-978
doi: 10.3321/j.issn:1000-467X.2002.09.011
杨季云, 曾祥元, 马布仁 . NF-κB信号传导途径对TNF-α诱导的SMMC-7721细胞凋亡的影响[J]. 癌症, 2002,21(9):974-978
doi: 10.3321/j.issn:1000-467X.2002.09.011
[7] Chen BA, Dong Y, Zhang P , et al. Reversal effect of tetrandrine in combination with droloxifene on cell line K562/A02 and the correlation with apoptosis induction[J]. Dong Nan Da Xue Xue Bao Yi Xue Ban, 2002,21(1):28-32
doi: 10.3760/j:issn:0253-2727.2002.12.015
陈宝安, 董颖, 张鹏 , 等. 汉防己甲素联合屈洛昔芬逆转K562/A02细胞耐药的研究[J]. 东南大学学报 (医学版), 2002,21(1):28-32
doi: 10.3760/j:issn:0253-2727.2002.12.015
[8] Chen BA, Qian XJ, Cheng J , et al. Effect of tetrandrine combined with droloxifen on the expression of bcr/abl of K562 at both mRNA and protein levels[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2005,13(1):95-99
doi: 10.3969/j.issn.1009-2137.2005.01.019
陈宝安, 钱习军, 程坚 , 等. 汉防己甲素联合屈洛昔芬对K562细胞bcr/abl表达的影响[J]. 中国实验血液学杂志, 2005,13(1):95-99
doi: 10.3969/j.issn.1009-2137.2005.01.019
[9] Yeh PY, Chuang SE, Yeh KH , et al. Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells[J]. Biochem Pharmacol, 2003,66(1):25-33
doi: 10.1016/S0006-2952(03)00250-8
[10] Chuang SE, Yeh PY, Lu YS , et al. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB(NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells[J]. Biochem Pharmacol, 2002,63(9):1709-1716
doi: 10.1016/S0006-2952(02)00931-0
[11] Chen F, Sun S, Kuhn DC , et al. Tetrandrine inhibits signal-induced NF-kappa B activation in rat alveolar macrophages[J]. Biochem Biophys Res Commun, 1997,231(1):99-102
doi: 10.1006/bbrc.1997.6057
[12] Sumitomo M, Tachibana M, Nakashima J , et al. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells[J]. J Urol, 1999,161(2):674-679
doi: 10.1016/S0022-5347(01)61993-1
[13] Romano MF, Lamberti A, Bisogni R , et al. Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel- specific decoy oligodeoxynucleotides[J]. Gene Ther, 2000,7(14):1234-1237
doi: 10.1038/
[14] Shi JH, Xu XP, Zhang ZL , et al. Inhibition of activation of nuclear factor-κB enhanced apoptosis of leukemic cells induced by homoharringtonine[J]. Zhonghua Nei Ke Za Zhi, 2003,42(5):292-295
史剑慧, 许小平, 张宗梁 , 等. 核因子-κB活化抑制增强高三尖杉酯碱诱导白血病细胞凋亡[J]. 中华内科杂志, 2003,42(5):292-295
[15] Cusack JC Jr, Liu R, Houston M , et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition[J]. Cancer Res, 2001,61(9):3535-3540
[1] Eric Wei Chiang Chan, Siu Kuin Wong, Hung Tuck Chan. An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots. Journal of Integrative Medicine, 2021, 19(4): 311-316.
[2] Shakti Rath, Rabindra N. Padhy. Antibacterial efficacy of five medicinal plants against multidrug-resistant enteropathogenic bacteria infecting under-5 hospitalized children. Journal of Integrative Medicine, 2015, 13(1): 45-57.
[3] Xin-min Li, Hui Chen, Yan-yan Ren, Yan-li Lu. Effects of Chinese herbal medicine Xifeng Capsule on multidrug resistance-associated protein 1 expression in hippocampus and cortex of rats with lithium-pilocarpine-induced epilepsy. Journal of Chinese Integrative Medicine, 2012, 10(8): 911-917.
[4] Bo Yang, Xue-chun Lu, Feng Zhang, Yang Liu, Hong-li Zhu. Inhibitory effects of traditional Chinese herbal medicine Tanreqing injection on proliferation of leukemia cells in vitro and the potential mechanisms. Journal of Chinese Integrative Medicine, 2011, 9(4): 414-422.
[5] Shuang-nian Xu , Jie-ping Chen, Jian-ping Liu, Yun Xia . Efficacy of arsenic trioxide for acute promyelocytic leukemia: A systematic review and meta-analysis. Journal of Chinese Integrative Medicine, 2009, 7(9): 801-808.
[6] Zhi Zheng , Ju Chen, Dong-yun Li, Xin-yi Chen. Effects of Compound Zhebei Granule plus doxorubicin on mdr1 gene expression in nude mice with K562/A02 tumor xenografts. Journal of Chinese Integrative Medicine, 2009, 7(8): 758-514.
[7] Shuang-nian Xu, Jie-ping Chen, Jian-ping Liu, Yun Xia. Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: A systematic review and meta-analysis. Journal of Chinese Integrative Medicine, 2009, 7(11): 1023-1034.
[8] Ya-lin Fu, Tao Chen. Research of traditional Chinese medicine in the treatment of leukemia: current status. Journal of Chinese Integrative Medicine, 2008, 6(8): 867-872.
[9] Nan-nan Chen, Shi-lin Huang, Yang Xiang, Li Zhang, De-jie Zhang. Effects of psoralen plus long-wave ultraviolet-A on apoptosis of HL-60 leukemia cells. Journal of Chinese Integrative Medicine, 2008, 6(8): 852-855.
[10] Feng Sun, Nan-nan Chen, Yu-bin Cheng. Compound realgar and natural indigo tablets in treatment of acute promyelocytic leukemia: a summary of experience in 204 cases. Journal of Chinese Integrative Medicine, 2008, 6(6): 639-642.
[11] Tan Li, Wei Wang, Tong Li. Antileukemic mechanism of resveratrol in vitro and in mice bearing L1210-tumor. Journal of Chinese Integrative Medicine, 2008, 6(12): 1267-1274.
[12] Shi-lin Huang, Nan-nan Chen, Yang Xiang, Chen Zhang, Li Zhang, De-jie Zhang. Effects of psoralen with long wave ultraviolet light on apoptosis and mitochondrial membrane potential in K562 cells. Journal of Chinese Integrative Medicine, 2008, 6(12): 1259-1262.
[13] Hong Liang, Yu Zhang, Jian-dong Zhang, Jian Gu, Li Ma, Xiao-ling Wang, Wei-gan Shen. Effects of arsenic trioxide on expressions of vascular endothelial growth factor and P-glycoprotein in multidrug resistant leukemia cell line K562/A02. Journal of Chinese Integrative Medicine, 2007, 5(6): 647-650.
[14] Nan-nan Chen, Shi-lin Huang, Yang Xiang, De-jie Zhang, Ai-xia Guo, Ai-ping Chen. Effects of inactivated rabbit serum containing compound realgar and natural indigo tablet on cell line NB4. Journal of Chinese Integrative Medicine, 2007, 5(1): 65-68.
[15] Wei Gu, Ya-ni Zhang, Bai Li, Jie Han, Bin-bin Cheng, Chang-quan Ling. Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics. Journal of Chinese Integrative Medicine, 2006, 4(3): 265-270.
Full text



[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239